Primary neuroendocrine tumors of ovary: A clinicopathological spectrum in a tertiary care hospital with review of literature

J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S623-S627. doi: 10.4103/jcrt.jcrt_28_22. Epub 2023 Apr 29.

Abstract

Aim: Primary neuroendocrine tumors in the ovary are rare. These tumors arise from the neuroendocrine cell system of ovarian stroma and surface epithelium, and may also arise from teratoma. We present four primary ovarian neuroendocrine tumors and discuss clinical, histomorphological, and immunohistochemical findings.

Methods: Four primary ovarian neuroendocrine tumors were identified from our 4-year departmental archives. H and E slides and immunostains were reviewed. Clinical history, imaging studies, and follow-up data were obtained from medical records.

Results: Patients' age ranged from 37 to 45 years. All the patients presented with abdominal discomfort, abnormal uterine bleeding, and unilateral or bilateral ovarian masses. Two of the cases were primary ovarian carcinoid tumors, one being the pure primary ovarian carcinoid tumor (PPOCT), and the other being associated with mature cystic teratoma, while the other two cases were neuroendocrine carcinoma. All the cases showed expression of neuroendocrine markers, namely, synaptophysin, chromogranin, and NSE.

Conclusions: Primary neuroendocrine tumors in the ovary are rare and consist of a group of heterogeneous tumors that express similar immunohistochemical markers.

Publication types

  • Review

MeSH terms

  • Adult
  • Carcinoid Tumor* / pathology
  • Female
  • Humans
  • Intestinal Neoplasms*
  • Middle Aged
  • Neuroendocrine Tumors* / diagnosis
  • Neuroendocrine Tumors* / pathology
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / pathology
  • Pancreatic Neoplasms*
  • Stomach Neoplasms*
  • Teratoma* / diagnosis
  • Teratoma* / pathology
  • Tertiary Care Centers

Supplementary concepts

  • Gastro-enteropancreatic neuroendocrine tumor